NCT05200559 2026-05-29T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid TumorsUniversity of PittsburghPhase 1/2 Active not recruiting25 enrolled
NCT05116189 2026-03-09KEYNOTE-B96Merck Sharp & Dohme LLCPhase 3 Active not recruiting643 enrolled 17 charts 1 FDA